Literature DB >> 8666155

The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations.

R V Considine1, E L Considine, C J Williams, T M Hyde, J F Caro.   

Abstract

Leptin-receptor gene expression in hypothalamic tissue from lean and obese humans was examined. The full-length leptin receptor, that is believed to transmit the leptin signal, is expressed in human hypothalamus. There was no difference in the amount of leptin-receptor mRNA In seven lean (BMI 23.3 +/- 0.9 kg/m2) and eight obese (BMI 36.9 +/- 1.5) subjects as determined by reverse transcription-polymerase chain reaction. A sequence polymorphism (A-->G) was detected at position 668 of the leptin receptor cDNA. This second base substitution changed a glutamine to an arginine at position 223 of the leptin receptor protein. Of 15 subjects analyzed, 11 were heterozygous for this base change and 3 were homozygous. The occurrence [correction of occurance] of the polymorphic allele(s) did not correlate with BMI in the population studied. The mutation responsible for the defect in the leptin receptor in db/db mice was not detected in any obese human, nor was the fa/fa rat mutation. These results provide evidence that the leptin resistance observed in obese humans is not due to a defect in the leptin receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666155     DOI: 10.2337/diab.45.7.992

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

1.  Recessive inheritance of obesity in familial non-insulin-dependent diabetes mellitus, and lack of linkage to nine candidate genes.

Authors:  S J Hasstedt; M Hoffman; M F Leppert; S C Elbein
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

2.  Leptin expression and action: new experimental paradigms.

Authors:  J S Flier
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

3.  Leptin and leptin receptor genetic variants associate with habitual physical activity and the arm body composition response to resistance training.

Authors:  S Walsh; C J Haddad; M A Kostek; T J Angelopoulos; P M Clarkson; P M Gordon; N M Moyna; P S Visich; R F Zoeller; R L Seip; S Bilbie; P D Thompson; J Devaney; H Gordish-Dressman; E P Hoffman; Thomas B Price; L S Pescatello
Journal:  Gene       Date:  2012-09-05       Impact factor: 3.688

Review 4.  Leptin in human physiology and pathophysiology.

Authors:  Christos S Mantzoros; Faidon Magkos; Mary Brinkoetter; Elizabeth Sienkiewicz; Tina A Dardeno; Sang-Yong Kim; Ole-Petter R Hamnvik; Anastasia Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-26       Impact factor: 4.310

5.  Presence of bovine leptin in edible commercial milk and infant formula.

Authors:  M Lage; R Baldelli; J P Camiña; J Rodriguez-Garci; A Peñalva; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

Review 6.  Leptin and obesity in humans.

Authors:  R V Considine
Journal:  Eat Weight Disord       Date:  1997-06       Impact factor: 4.652

7.  DNA methylation of leptin and adiponectin promoters in children is reduced by the combined presence of obesity and insulin resistance.

Authors:  M C García-Cardona; F Huang; J M García-Vivas; C López-Camarillo; B E Del Río Navarro; E Navarro Olivos; E Hong-Chong; F Bolaños-Jiménez; L A Marchat
Journal:  Int J Obes (Lond)       Date:  2014-02-19       Impact factor: 5.095

Review 8.  Leptin and the sympathetic connection of fat to bone.

Authors:  M W Hamrick; S L Ferrari
Journal:  Osteoporos Int       Date:  2007-10-09       Impact factor: 4.507

9.  Serum leptin levels in acromegalic patients before and during somatostatin analogs therapy.

Authors:  R Baldelli; C Durante; E D'Amico; F Diacono; G Tamburrano; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

Review 10.  Obesity-related hypertension: is there a role for selective leptin resistance?

Authors:  Marcelo L G Correia; William G Haynes
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.